Speakers

Sara Hamilton is the Clinic Manager for the Department of Neurology at Washington University School of Medicine, where she oversees clinical operations for the Department’s outpatient pediatric clinics. Sara is also the mother of a child with Fragile X Syndrome who has worked closely with local, state, and national organizations focused on Fragile X education and advocacy for more than a decade. Sara has served as the Vice President and President of the Fragile X Resource Center of Missouri, a Community Support Network Leader with The National Fragile X Foundation, and as a Family Ambassador for FRAXA, the national organization focused on advancing Fragile X research.

Peter Marks received his graduate degree in cell and molecular biology and his medical degree at New York University and completed Internal Medicine residency and Hematology/Medical Oncology training at Brigham and Women’s Hospital in Boston. He has worked in academic settings teaching and caring for patients and in industry on drug development and is an author or co-author of over 100 publications. He joined the FDA in 2012 as Deputy Center Director for CBER and became Center Director in 2016. Over the past several years he has been integrally involved in the response to various public health emergencies and in 2022 he was elected a member of the National Academy of Medicine.